vs
Orthofix Medical Inc.（OFIX）与null（SWIM）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是null的1.9倍（$219.9M vs $117.3M），Orthofix Medical Inc.净利率更高（-1.0% vs -7.3%，领先6.3%），null同比增速更快（5.3% vs 2.0%），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -14.4%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
该企业是一家源自美国的跨国律师事务所，1934年创立于加利福尼亚州洛杉矶，在诉讼业务、公司法务以及监管合规法律领域拥有深厚的行业积累与知名度，是全球颇具影响力的综合性律所之一。
OFIX vs SWIM — 直观对比
营收规模更大
OFIX
是对方的1.9倍
$117.3M
营收增速更快
SWIM
高出3.3%
2.0%
净利率更高
OFIX
高出6.3%
-7.3%
两年增速更快
OFIX
近两年复合增速
-14.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $117.3M |
| 净利润 | $-2.2M | $-8.5M |
| 毛利率 | 71.1% | 31.7% |
| 营业利润率 | 0.2% | — |
| 净利率 | -1.0% | -7.3% |
| 营收同比 | 2.0% | 5.3% |
| 净利润同比 | 92.4% | -43.1% |
| 每股收益（稀释后） | $-0.05 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXSWIM
| Q1 26 | — | $117.3M | ||
| Q4 25 | $219.9M | $100.0M | ||
| Q3 25 | $205.6M | $161.9M | ||
| Q2 25 | $203.1M | $172.6M | ||
| Q1 25 | $193.6M | $111.4M | ||
| Q4 24 | $215.7M | $87.3M | ||
| Q3 24 | $196.6M | $150.5M | ||
| Q2 24 | $198.6M | $160.1M |
净利润OFIXSWIM
| Q1 26 | — | $-8.5M | ||
| Q4 25 | $-2.2M | $-7.0M | ||
| Q3 25 | $-22.8M | $8.1M | ||
| Q2 25 | $-14.1M | $16.0M | ||
| Q1 25 | $-53.1M | $-6.0M | ||
| Q4 24 | $-29.1M | $-29.2M | ||
| Q3 24 | $-27.4M | $5.9M | ||
| Q2 24 | $-33.4M | $13.3M |
毛利率OFIXSWIM
| Q1 26 | — | 31.7% | ||
| Q4 25 | 71.1% | 28.0% | ||
| Q3 25 | 72.2% | 35.4% | ||
| Q2 25 | 68.7% | 37.1% | ||
| Q1 25 | 62.8% | 29.5% | ||
| Q4 24 | 69.0% | 24.6% | ||
| Q3 24 | 68.7% | 32.4% | ||
| Q2 24 | 67.8% | 33.1% |
营业利润率OFIXSWIM
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | -10.7% | ||
| Q3 25 | -8.3% | 13.3% | ||
| Q2 25 | -7.9% | 14.3% | ||
| Q1 25 | -25.2% | -4.4% | ||
| Q4 24 | -5.3% | -14.9% | ||
| Q3 24 | -9.6% | 8.9% | ||
| Q2 24 | -12.5% | 12.5% |
净利率OFIXSWIM
| Q1 26 | — | -7.3% | ||
| Q4 25 | -1.0% | -7.0% | ||
| Q3 25 | -11.1% | 5.0% | ||
| Q2 25 | -6.9% | 9.3% | ||
| Q1 25 | -27.4% | -5.4% | ||
| Q4 24 | -13.5% | -33.4% | ||
| Q3 24 | -13.9% | 3.9% | ||
| Q2 24 | -16.8% | 8.3% |
每股收益（稀释后）OFIXSWIM
| Q1 26 | — | $-0.07 | ||
| Q4 25 | $-0.05 | $-0.06 | ||
| Q3 25 | $-0.57 | $0.07 | ||
| Q2 25 | $-0.36 | $0.13 | ||
| Q1 25 | $-1.35 | $-0.05 | ||
| Q4 24 | $-0.76 | $-0.24 | ||
| Q3 24 | $-0.71 | $0.05 | ||
| Q2 24 | $-0.88 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | — |
| 总债务越低越好 | — | $3.3M |
| 股东权益账面价值 | $450.0M | $396.7M |
| 总资产 | $850.6M | $856.4M |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资OFIXSWIM
| Q1 26 | — | — | ||
| Q4 25 | $82.0M | — | ||
| Q3 25 | $62.9M | — | ||
| Q2 25 | $65.6M | — | ||
| Q1 25 | $58.0M | — | ||
| Q4 24 | $83.2M | — | ||
| Q3 24 | $30.1M | — | ||
| Q2 24 | $26.4M | — |
总债务OFIXSWIM
| Q1 26 | — | $3.3M | ||
| Q4 25 | — | $279.8M | ||
| Q3 25 | $157.2M | $281.1M | ||
| Q2 25 | $157.0M | $281.5M | ||
| Q1 25 | $156.9M | $306.9M | ||
| Q4 24 | $157.0M | $281.5M | ||
| Q3 24 | $118.5M | $282.8M | ||
| Q2 24 | $118.0M | $282.4M |
股东权益OFIXSWIM
| Q1 26 | — | $396.7M | ||
| Q4 25 | $450.0M | $405.9M | ||
| Q3 25 | $442.5M | $408.4M | ||
| Q2 25 | $458.3M | $398.4M | ||
| Q1 25 | $458.3M | $381.1M | ||
| Q4 24 | $503.1M | $387.2M | ||
| Q3 24 | $525.9M | $416.6M | ||
| Q2 24 | $546.0M | $408.1M |
总资产OFIXSWIM
| Q1 26 | — | $856.4M | ||
| Q4 25 | $850.6M | $823.2M | ||
| Q3 25 | $832.6M | $844.4M | ||
| Q2 25 | $837.2M | $822.1M | ||
| Q1 25 | $823.1M | $824.6M | ||
| Q4 24 | $893.3M | $794.2M | ||
| Q3 24 | $867.9M | $853.4M | ||
| Q2 24 | $882.0M | $830.0M |
负债/权益比OFIXSWIM
| Q1 26 | — | 0.01× | ||
| Q4 25 | — | 0.69× | ||
| Q3 25 | 0.36× | 0.69× | ||
| Q2 25 | 0.34× | 0.71× | ||
| Q1 25 | 0.34× | 0.81× | ||
| Q4 24 | 0.31× | 0.73× | ||
| Q3 24 | 0.23× | 0.68× | ||
| Q2 24 | 0.22× | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $-47.7M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | — |
| 自由现金流率自由现金流/营收 | 7.6% | — |
| 资本支出强度资本支出/营收 | 4.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | — |
8季度趋势，按日历期对齐
经营现金流OFIXSWIM
| Q1 26 | — | $-47.7M | ||
| Q4 25 | $27.7M | $23.3M | ||
| Q3 25 | $12.4M | $51.0M | ||
| Q2 25 | $11.6M | $36.0M | ||
| Q1 25 | $-18.4M | $-46.9M | ||
| Q4 24 | $23.7M | $6.2M | ||
| Q3 24 | $11.7M | $37.2M | ||
| Q2 24 | $9.0M | $52.4M |
自由现金流OFIXSWIM
| Q1 26 | — | — | ||
| Q4 25 | $16.8M | $14.1M | ||
| Q3 25 | $2.5M | $45.2M | ||
| Q2 25 | $4.5M | $29.1M | ||
| Q1 25 | $-25.1M | $-50.3M | ||
| Q4 24 | $15.2M | $-98.0K | ||
| Q3 24 | $6.3M | $33.2M | ||
| Q2 24 | $-360.0K | $47.9M |
自由现金流率OFIXSWIM
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | 14.1% | ||
| Q3 25 | 1.2% | 27.9% | ||
| Q2 25 | 2.2% | 16.8% | ||
| Q1 25 | -13.0% | -45.2% | ||
| Q4 24 | 7.0% | -0.1% | ||
| Q3 24 | 3.2% | 22.1% | ||
| Q2 24 | -0.2% | 29.9% |
资本支出强度OFIXSWIM
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | 9.2% | ||
| Q3 25 | 4.8% | 3.6% | ||
| Q2 25 | 3.5% | 4.0% | ||
| Q1 25 | 3.5% | 3.1% | ||
| Q4 24 | 4.0% | 7.2% | ||
| Q3 24 | 2.7% | 2.7% | ||
| Q2 24 | 4.7% | 2.8% |
现金转化率OFIXSWIM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 6.29× | ||
| Q2 25 | — | 2.25× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.32× | ||
| Q2 24 | — | 3.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
SWIM
暂无分部数据
